Biopixlar® - a new paradigm

3D single-cell bioprinting

Biopixlar® represents a new paradigm in bioprinting. The open volume microfluidic technology lets you build functional tissues directly using the cells you want – without the need for any bioink or other carrier material.

Thanks to its high precision cell deposition technology, you can bring your detailed tissue designs to life without having to compromise. Read on to find out how we transform medical research and drug development – cell by cell.

Print any cell

The ability print any cell type with single-cell precision opens up a whole new world of possibilities in everything from fundamental biological research to drug development and regenerative medicine. Biopixlar lets you print even the most demanding cell types in any configuration, from single-cell arrays to organoids and complex tissues. The high precision microfluidic cell deposition technology promotes intercellular communication and ensures high cell viability.

Biopixlar has been used to print hepatocytes, beta cells, cardiomyocytes, T-cells, primary neurons, IPSCs, MSCs, corneal cells, melanoma and adenocarcinoma cells, neuroblastomal cells, fibroblasts, renal epithelial cells, keratinocytes, and much more…

Biopixlar features

Single-cell resolution

Design biological tissues by printing details down to the level of individual cells.

High-precision and reproducibility

Structure biological tissues by precisely controlling the spatial deposition of your living cells and benefit from high reproducibility across replicates.

>95 % cell viability

The printing process is optimized to minimize the shear forces on the cell sample, achieving very high cell viability (cell viability was tested across multiple cell lines).

Multi-cellular models

Compose your biological tissue by printing up to three different cell types from the same printhead. By changing the printhead, new cell types can be printed.

Real-time monitoring

Follow the printing process in real-time with the fully integrated multi-color fluorescence imaging setup.

Ideal for valuable cell sources

Biopixlar is designed for handling scarce and valuable cell sources such as stem cells, primary cells and patient biopsies.

The BIOPIXLAR advantage

Biopixlar

Extrusion

Stereoelithography

Inkjet

Laser assisted

Printing resolution

+++

+

++++

++

++

Small volume capacity

++++

+

++

+++

+++

Throughput

++

+++

+

++++

+

Fast sample preparation

++++

++

++

+++

+

Large tissue models

+

++++

+++

+

++

No carrier material requirement

++++

+

+

++

+

Cell stress prevention

++++

+

++

+++

+++

Cell on cell printing

++++

+

+

+

+

No need for crosslinking

++++

+

++++

+++

++++

Cell confluency post printing

++++

++

++

+++

++

Cell to non-carrier material interaction

++++

+

+

+++

+

Tissue model cell to cell interaction

++++

+

+

+++

+

what our customers say

Fluicell’s technology is the first of its kind to enable single-cell resolution bioprinting with precision, speed and reproducible accuracy, even in 3D, in a way that was not possible before.

Dr. Luiz Bertassoni, Director Knight Cancer Precision Biofabrication Hub

The BioPen System is one of the best single-cell treatment systems on the market. It is easy-to-use, and gives me beautiful, publication-ready movies.

Dr. Dani Cai, National Institute of Health

The BioPen system provides us with unique data; with it, you are able to see how cell processes are trapped.

Prof. Megan Rizzo, University of Maryland Medical Center

The BioPen product is well designed and works even better than we could have hoped. The team is very reliable with customer support. I would highly recommend purchasing this product.

Dr. Veronica Jove, Rockefeller University

The Dynaflow Resolve system is a very reliable and efficient tool for automated compound application with excellent performance in fast solution exchange.

Dr. Timm Danker, NMI TT

Previous

Next

Partner with us!

Learn about what we hope to achieve in partnership with innovation-driven pharmaceutical companies. Have questions or interested in exploring a collaboration? Get in touch.